Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | leukotriene A4 hydrolase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | leukotriene A 4 hydrolase | Get druggable targets OG5_129538 | All targets in OG5_129538 |
Candida albicans | leukotriene A4 hydrolase/leucyl aminopeptidase | Get druggable targets OG5_129538 | All targets in OG5_129538 |
Loa Loa (eye worm) | leukotriene A4 hydrolase | Get druggable targets OG5_129538 | All targets in OG5_129538 |
Schistosoma mansoni | leukotriene A4 hydrolase (M01 family) | Get druggable targets OG5_129538 | All targets in OG5_129538 |
Echinococcus multilocularis | leukotriene A 4 hydrolase | Get druggable targets OG5_129538 | All targets in OG5_129538 |
Candida albicans | leukotriene A4 hydrolase/leucyl aminopeptidase | Get druggable targets OG5_129538 | All targets in OG5_129538 |
Schistosoma japonicum | ko:K01254 leukotriene-A4 hydrolase [EC3.3.2.6], putative | Get druggable targets OG5_129538 | All targets in OG5_129538 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Leishmania major | aminopeptidase-like protein,metallo-peptidase, Clan MA(E), Family M1 | leukotriene A4 hydrolase | 611 aa | 508 aa | 22.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | p450 reductase, putative | 0.0116 | 0.2623 | 1 |
Brugia malayi | flavodoxin family protein | 0.0116 | 0.2623 | 0.7907 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0116 | 0.2623 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0116 | 0.2623 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0116 | 0.2623 | 0.5 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0116 | 0.2623 | 0.2152 |
Trypanosoma cruzi | p450 reductase, putative | 0.0116 | 0.2623 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 0.2623 | 0.2152 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0116 | 0.2623 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0116 | 0.2623 | 0.2152 |
Giardia lamblia | Hypothetical protein | 0.0103 | 0.2022 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0116 | 0.2623 | 0.2152 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0116 | 0.2623 | 1 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0116 | 0.2623 | 0.2623 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0072 | 0.0601 | 0.0601 |
Echinococcus multilocularis | leukotriene A 4 hydrolase | 0.0279 | 1 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0103 | 0.2022 | 0.5 |
Chlamydia trachomatis | sulfite reductase | 0.0072 | 0.0601 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0116 | 0.2623 | 0.5 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0116 | 0.2623 | 0.2152 |
Brugia malayi | hypothetical protein | 0.0128 | 0.3159 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0116 | 0.2623 | 0.7907 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0116 | 0.2623 | 0.5 |
Loa Loa (eye worm) | leukotriene A4 hydrolase | 0.0279 | 1 | 1 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0116 | 0.2623 | 0.5 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0116 | 0.2623 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0116 | 0.2623 | 0.2152 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0116 | 0.2623 | 0.5 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0116 | 0.2623 | 0.5 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0116 | 0.2623 | 1 |
Schistosoma mansoni | leukotriene A4 hydrolase (M01 family) | 0.0279 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 2000 nM | Inhibition of human recombinant LTA4-h by peptidase assay | ChEMBL. | 18394906 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.